Evaluation of Dolutegravir Interactions With Artemether-Lumefantrine and Amodiaquine-Artesunate
Phase of Trial: Phase I
Latest Information Update: 07 Mar 2018
At a glance
- Drugs Dolutegravir (Primary) ; Artemether/lumefantrine; Artesunate/amodiaquine
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Acronyms DolACT
- 07 Mar 2018 Results presented at the 25th Conference on Retroviruses and Opportunistic Infections
- 04 Oct 2016 Status changed from recruiting to completed.
- 10 May 2016 Planned End Date changed from 1 Mar 2016 to 1 Sep 2016.